On April 17, 2024, in connection with the determination by the Board of Directors of Soleno Therapeutics, Inc. at the Company?s 2024 Annual Meeting of Stockholders Gwen Melincoff, a current director, notified the Company that she does not intend to stand for re-election to the Board at the 2024 AGM.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.08 USD | -1.29% | +2.24% | +4.55% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.55% | 1.53B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Soleno Therapeutics, Inc. Announces Gwen Melincoff, Intends Not Intend to Stand for Re-Election as Director